Skip to content

Clinical trials

Carcinoma, Squamous Cell trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Squamous Cell Country / region: Japan Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20081
20121
20151
20171
20202
20211
20231
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Recruiting3
Terminated2
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
AstraZeneca1
Boehringer Ingelheim1
Eli Lilly and Company1
Hamamatsu University1
Incyte Corporation1
Japan Clinical Oncology Group1
Johnson & Johnson Enterprise Innovation Inc.1
Merck Sharp & Dohme LLC1
Regeneron Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Squamous Cell12
Carcinoma, Non-Small-Cell Lung3
Head and Neck Neoplasms3
Squamous Cell Carcinoma of Head and Neck3
Esophageal Neoplasms2
Neoplasm Metastasis2
Adenocarcinoma1
Anus Neoplasms1
Carcinoma, Adenosquamous1
Carcinoma, Large Cell1

Trials

Showing 76 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.